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ABSTRACTS OF SECOND INTERNATIONAL CONFERENCE ON ALZHEIMER'S  DISEASE 
CLINICAL COURSE 
diagnoses, and 5.3 correct etiological diagnoses. In contrast, all 
syndromal and etiological diagnoses made by EVINCE were correcL 
Moreover, the disciplines displayed significant preferences for 
certain diagnoses. For example, neurologists used the diagnosis AD 
more often than clinicians from other disciplines. The experiments 
show that EVINCE can be considered a good replica of medical 
expertise on the subject matter. Because standardized diagnostic 
procedures are essential for research into etiology, pathogenesls and 
experimental interventions in dementia patients, especially in 
Alzhelmer's Disease, the ES EVINCE could be an important tool. 
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NEUROPSYCHOLOGICAL EVALUATION OF PATIENTS SUSPEC- 
TED OF EARLY ALZHEIMER'S DISEASE: EXPERIMENTAL STUDIES 
WITH AGE ASSOCIATED MEMORY IMPAIRMENT AND DYSTHYMIA. 
• E. Reyersen van Buuren, J. Jolles and P.J, Houx. Dept. Neuro- 
psychology a Psychoblologle; Limburg University; Box 616; 6200 MD 
Maastrleht; The Netherlands. 
It appears to be very difficult -if at all possible- to detect 
Alzhe lmer ' s  d e s e a s e  in s t a g e s  in which no demen t i a  is p r e sen t .  In 
t he  e a r l i e r  s t a g e s  (2 and 3 on t he  Global Def lora t ion  Sca l e -  
Reisberg)  cogn i t i ve  d y s f u n c t i o n s  can  be a s s e s s e d  bu t  it  is not c l ea r  
whether  t h e se  sub jec t s  ma y  deve lop  AD l a t e r  in life. Longi tudina l  
r e s e a r c h  is n e c e s s a r y  to e v a l u a t e  such  a hypo thes i s .  As a f i r s t  s tep  
in a l a rge  l ong i tud ina l  fol lowup s t u d y  in the  Alzhe imer  r e s e a r c h  
center  in Maas t r l ch t ,  The  Ne the r l ands ,  we e v a l u a t e d  the  n a t u r e  of 
t he  cogn i t i ve  d y s f u n c t i o n s  in p a t i e n t s  who a r e  s u s pe c t ed  to he in 
an ear ly  s tage  of p r i ma ry  d e g e n e r a t i v e  demen t i a  or to be a t  rise to 
be a f f l i c t ed  by such a condi t ion.  In a f i r s t  expe r imen t ,  15 subjec t s  
aged 41 t h rough  60 who were  d iagnosed  as su f f e r ing  from d y s -  
t hymlc  d i sorder  were  compared  to 16 h e a l t h y  age  ma tched  controls .  
I t  a p p e a r e d  t h a t  t h e r e  were  def ic i t s  in s e c o n d a r y  memory l ike 
aqu i s i t i on  and a c t i v e  r e t r i e v a l  from memory; in addi t ion ,  memory 
conso l ida t ion  and ge ne ra l  speed of in format ion  process ing  were 
i n f e r io r  in t he  p a t i e n t s ,  The re  were no def ic i t s  in p r imary  memory 
such as in digi t  span  and in block span.  Iden t i ca l  f indings  were 
clone in the  second e x p e r i m e n t  in which 20 p a t i e n t s  su f f e r ing  from 
Age Assoc ia ted  Memory Impa i rmen t  (AAMI, age  4 0 - 7 0  yea r s )  were 
compared  to ma tched  cont ro ls .  A two y e a r s  follow up of subjec ts  
from the  2 s t ud i e s  has  been done. At the  follow up a s s e s s m e n t  it  
a p p e a r e d  t h a t  the  pe r fo rma nc e  of p a t i e n t s  w i thou t  depress ion  was 
in fe r io r  to t h a t  of  p a t i e n t s  with depress ion .  The r e s u l t s  of t hese  
s t u d i e s  a r e  i n d i c a t i v e  of  t he  r e l e v a n c e  of neuropsycho log ica i  
c o n t r i b u t i o n s  to e a r l y  d iagnos i s  of d e g e n e r a t i v e  bra in  d i sease ,  
e s p e c i a l l y  AD. T he  s e n s i t i v i t y  of cogn i t ive  neuropsycho log iea l  
methods enables an objective establishment of minor cognitive 
dysfunctions which are not evident with gross, psychometric tests 
and observation scales. The use of these measures for longitudinal 
research on early phases of Alzheimer's disease is recommended. 
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CLINICAL MARKERS OF EARLY ALZHEIMERS DISEASE. *S.H. Ferris, 
C. Flicker, B. Relsberg, M.J. de Leon. Aging and Dementia 
Research Center, NYU Medical Center, New York, 10016 USA. 
We will review recent research seeking to identify or 
develop an early clinical marker for Alzheimers disease (AD), 
i.e., a reliable and valid measure that can be detected before 
the onset of cognitive symptoms or before these symptoms are 
severe enough to warrant a clinical diagnosis of AD. Such an 
early marker would be extremely useful for studying the early 
course and pathophyslology of AD, since the marker would enable 
reseachers to select "enriched" study samples containing 
subjects at high risk for developing AD clinically over the 
subsequent several years. Promising research directions in the 
search for early predictors of AD include study of specific 
patterns of mild cognitive deficit, use of %D v~v O brain imaging 
techniques to detect signs of early atrophic change, sensory 
system deficits and patterns of electrophysiological 
abnormality. The status of these and other current approaches 
will be discussed. 
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PSYCHOPATHOLOGY AND FRONTAL LOBE INVOLVEMENT IN PRIMARY 
DEGENERA'ITV'E AND VASCULAR DEMENTIA. 1. CLINICAL ASPECTS. 
Lars Gustafson*, Department of Psychogeriatries, Arne Brun Department of 
Pathology, University of Lund, Lurid, Sweden 
The aim of the study was to analyse the diagnostic significance of fro- 
ntal lobe symptoms in dementia. These symptoms are most frequent in Pick's 
disease and frontal lobe dementia of non-Alzheimer type. Their presence in 
other dementias may complicate the diagnostic decision. 
These clinical questions have been analysed in a longitudinal dementia 
study. The patients went trough a neuropsychiatric investigation including 
EgG, regional cerebral blood flow (rCBF) measurement (133 Xe inhalation 
technique) and in most cases CT. 28 patients with progressive dementia and 
marked personality changes and other indications of frontal lobe dysfunc- 
tion were selected for the study. 
Results from five patient groups based on the neuropathological findings 
are presented. Group 1) Dementia of Ahheimer type (DAT) with frontal pre- 
dominance. This group contained four cases with a mean age at death of 78 
:t: 7,6 years. They showed a typical Alzheimer type dementia with dysmnesia, 
dysphasia, dyspraxia and spatial disorientation. In addition to this howe- 
ver they showed aggressiveness, inadequate laughing, vocally disruptive 
behaviour and other frontal lobe symptoms already at an early stage of the 
disease. Group 2) Three cases with mainly fronto bilateral selective in- 
complete white matter infarction (SIWI). The mean age at death was 72 ± 13 
years. The patients showed progressive personality changes with an irrita- 
bility and unrestrained behaviour in combination with memory failure and 
gait disturbances. Psychotic reactions with visual hallucinosis were found 
in two cases and the differential diagnosis against nonorganic mental 
diseases was difficult. Blood pressure was generally low in this group 
(mean blood preasure 96 ± 12 mm Hg). Group 3) Binswanger's disease. Three 
cases with a mean age at death of 74 ± 7 years. The dementia was progres- 
sive with episodic deterioration and epileptic phenomena. The frontal lobe 
involvment was mainly indicated by emotional symptoms such as euforia and 
apathy. Vascular dementia was indicated by the clinical features but dif-  
ferential diagnosis against DAT was difficult. Group 4) contained two uni- 
que cases with frontal vascular lesions. Group 5) contained sixteen cases 
of degenerative frontal lobe dementia of non-Ahheimer type (FLD). 
In conclusion. Symptoms indicating frontal lobe damage are common in both 
vascular and primary degenerative dementias. Differential diagnosis of 
dementia has to consider the type and severety of the frontal lobe symp- 
toms, the time of debut, and the combination with other psychiatric and 
neurological symptoms. Differential diagnosis against nonorganic mental 
diseases may be difficult especially in dementia with duration over 15-20 
years, as was the case in several of our patients. 
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A BRIEF ASSESSMENT BATTERY FOR THE DIAGNOSIS OF 
PROBABLE ALZHEIMER'S DISEASE. * M.C.Tierney, G. 
Snow, A. Mores, M.L. ZorzJtto, R. Fisher, D. Reld. 
Sunnybrook Health Science Centre, University of 
Toronto, Toronto, Canada, M4N3M5. 
The NINCDS-ADRDA diagnostic criteria for 
Alzheimer's Disease have received wide acceptance in 
research protocols. Studies examining their 
validity have been promising. Use of these 
criteria, however, necessitates lengthy and costly 
assessment of patients. The purpose of this study 
was to determine whether a reduction in the number 
of assessments could produce as accurate a 
discrimination as the full battery. Our sample 
consisted of 197 participants each of whom had 
individual medical, neuro-psychological and 
behavioural assessments based on the NINCDS-ADRDA 
criteria. Participants were then classified as 
neurologically normal (N=96), Probable Alzheimer's 
(N=56) or 'Other Dementias' (N=45). More than 50 
clinical measures were administered to our 
participants as part of the diagnostic work-up. 
Discrlmlnant functlon analyses indicated that a 
small battery of neuropsychologlcal and neurological 
measures differentiated among the three groups with 
i00~ accuracy. This battery requires no more than 
thirty minutes to administer. While this level of 
accuracy has been reported in some studies which 
differentiated normals from dementing individuals, 
no previous study to date has ever reported such 
high accuracy rates in the distinction among the 
dementias. 
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INCREASED SERUM INSOLIN-LIKE GROWTH FACTOR-I 
CONCENTRATIONS IN INSTITUTIONALIZED WOMEN WITH 
ALZHEIMER'S DISEASE. LR Donahue, SCJ Rosen, AA 
Spindler, JF Nichols, JW Ramsdell,and MJ Renvall. 
Dept. of Internal Medlcine, University of California 
San Diego, and the Dept.of Nutritio~ University of 
Maine, Orono Maine 04473, USA. 
Variable changes in growth hormone (GH) 
concentration have been reported in Alzheimer's 
patients (ALZ). Insulin-like growth factor-I 
